Clinical trials: Time in Range
Time in Range
Feasibility of DPP-4 Inhibitor Therapy on Advanced Hybrid Closed Loop System
Background: Ramadan Iftar meal typically causes glucose excursions. Dipeptidyl peptidase-4 inhibitors increase serum concentrations of glucagon-like peptide-1 and thus, decrease blood glucose levels with low risk of hypoglycemia.
- Trial name
- NCT06021119
- Testing
- Dipeptidyl peptidase-4 inhibitors
- Where
- Egypt
- Volunteers
- 50 people
- Sponsor
- Ain Shams University
Diabetes, Diabetes (DM)
Time in rANge vs. Time in nOrmal Glycemia for Better Glycemic Control
The TANGO study is a 12-month study involving 120 children and adolescents with Type 1 Diabetes (T1D) across the Czech Republic, Israel, and Poland who use automated insulin delivery (AID) systems.
- Conditions
- Diabetes, Diabetes (DM), Diabetes Type 1
- Trial name
- TANGO (NCT07376850)
- Testing
- Structured Diabetes Education, Automated Insulin Delivery (AID) System Adjustment
- Where
- 3 sites in Czechia, Israel and 1 more
- Volunteers
- 120 people
- Sponsor
- University Hospital, Motol
Type 2 Diabetes
My Diabetes Study - CGM Initiation Approach & Time In Range
This study includes two phases. The purpose of Phase 1 of this study is to understand if there is a difference between two ways of introducing a continuous glucose monitor (CGM) to people with type 2 diabetes (T2D).
- Trial name
- NCT05928572
- Testing
- CGM initiation approach
- Where
- United States
- Volunteers
- 159 people
- Sponsor
- Holly Willis
Time in Range, Artificial Intelligence
Insulin Dose Calculation Software in Insulin Therapy
Insulin therapy is the mainstream glucose-lowering program for hospital glucose management. Intelligent insulin dose calculation software based on fingertip glucose monitoring is born in response to the situation.
- Conditions
- Time in Range, Artificial Intelligence, Insulin Therapy
- Trial name
- IDCST (NCT05389839)
- Testing
- Wechat program
- Where
- China
- Volunteers
- 182 people
- Sponsor
- xiaolong zhao
Type 1 Diabetes
Clinical Utility of Tight Objectives of Advanced Hybrid Closed-loop Systems Among Type 1 Diabetes Patients (TightT1AHCL)
Diabetes is a chronic disease with a relevant public health burden. Maintaining blood glucose levels as close to normal as possible is essential to avoid the associated microvascular and macrovascular complications.
- Trial name
- TightT1AHCL (NCT06466967)
- Testing
- Advanced hybrid closed-loop CamAPS FX
- Where
- Spain
- Volunteers
- 40 people
- Sponsor
- Castilla-La Mancha Health Service
Diabetes Mellitus, Type 2
Glucose Monitoring Comparison in Primary Care
This research trial will randomize 50 primary care clinics and 354 patients in accordance with their primary care clinic assignment to 2 different glucose monitoring strategies (SMBG vs.
- Trial name
- GluCoCare (NCT05222815)
- Testing
- CGM, SMBG
- Where
- United States
- Volunteers
- 360 people
- Sponsor
- HealthPartners Institute
Knee Osteoarthritis
End-range Mobilization on Time Curve of Pressure Pain Threshold
Pain in knee osteoarthritis (OA) represents increased pain intensity due to peripheral and central sensitivity. Pressure pain threshold (PPT) is a widely applied technique for measuring the magnitude of peripheral and central…
- Trial name
- NCT04629625
- Testing
- End-range mobilization, Non end-range mobilization
- Where
- 2 sites in Hungary
- Volunteers
- 66 people
- Sponsor
- University of Pecs
Type 1 Diabetes Mellitus (T1DM), Diabetes Distress
GlycoQuest: An AI-Adaptive CGM-Integrated Serious Game for Pediatric Type 1 Diabetes
Type 1 diabetes diagnosed in childhood requires rapid acquisition of complex self-management skills while children and caregivers are also adapting emotionally and socially to a chronic condition.
- Conditions
- Type 1 Diabetes Mellitus (T1DM), Diabetes Distress, Hypoglycemia (Diabetic), Family Conflict
- Trial name
- GlycoQuest (NCT07726680)
- Testing
- GlycoQuest Digital Therapeutic, Enhanced Digital Psychoeducation
- Where
- Pakistan
- Volunteers
- 110 people
- Sponsor
- Shifa International Hospital
Type 1 Diabetes Mellitus
Comparing Continuous With Flash Glucose Monitoring in Adults With Type 1 Diabetes
The present study wants to compare the Dexcom G6® continuous glucose monitoring (CGM) system (experimental group) with the FreeStyle Libre flash glucose monitoring (FGM) system (control group).
- Trial name
- ALERTT1 (NCT03772600)
- Testing
- Dexcom G6 CGM
- Where
- 6 sites in Belgium
- Volunteers
- 269 people
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
Type 1 Diabetes
Hybrid Closed Loop System for Patients on Multiple Daily Insulin Injections
The objective of this study is to assess structured group education onboarding protocol of the 670 G Hybrid Closed Loop (HCL) systems in achieving glucose control of patients on Multiple Daily Insulin Injections (MDI).
- Trial name
- NCT04145804
- Testing
- Medtronic Minimed 670G insulin pump
- Where
- Qatar
- Volunteers
- 40 people
- Sponsor
- Hamad Medical Corporation
Management of Anticoagulation
Improved Time in Therapeutic Range With Patient Self-Testing of Their INR Compared to Usual Care
Patients who receive a mechanical heart valve to replace a diseased heart valve must take an anticoagulation medicine the rest of their lives, and monitor their level of anticoagulation.
- Trial name
- NCT00703963
- Testing
- INRatio monitor by Hemosense, Usual Care
- Where
- United States
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- Mayo Clinic
Kidney Transplant; Complications
Pulse Wave Velocity, Tacrolimus Time in Therapeutic Range and CV in African American Kidney Transplants
The primary purpose of this study is to evaluate the pulse wave velocity and vascular compliance measurements at the beginning and the end of the study while the participants are taking either extended release tacrolimus tablets…
- Trial name
- PTAAK (NCT03841097)
- Testing
- Extended Release Tacrolimus Tablets, Immediate Release Tacrolimus Capsule
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- Roy D. Bloom, MD
Type 2 Diabetes, Diabetes Related Complications
Time-In-Range Based Risk Stratification of Type 2 Diabetes Microvascular Complications
The goal of this observational study is to learn about the role of Time-in-Range to stratify the risk of micro vascular complications in adults with type 2 diabetes. The main questions it aims to answer are: 1.
- Conditions
- Type 2 Diabetes, Diabetes Related Complications, Diabetes; Retinopathy (Manifestation), Diabetes; Neuropathy, Polyneuropathy (Manifestation)
- Trial name
- TRACK2 (NCT05787990)
- Testing
- Diabetes Microvascular Complication Tests
- Where
- Singapore
- Volunteers
- 500 people
- Sponsor
- Singapore General Hospital
Diabetes Mellitus, Type 1
Long-term, Implantable Sensor Improves Health Outcomes in Patients With T1D
The implantable Eversense ® CGM System obtained CE marking in 2016 for the 90-day device and in 2017 for the 180-day device.There is interest in real-world clinical evidence on the use of Eversense regarding changes in HbA1c and…
- Trial name
- NCT04160156
- Testing
- Long term sensor
- Where
- Italy
- Volunteers
- 100 people
- Sponsor
- University Magna Graecia